$AMST
Amesite Inc. Stock $amst

$amst Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000121390022059740 Filed on September 28, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022
Revenue	$280.3K	$157.6K	$697.0K
YoY Change	99.22%	-38.49%	3.32%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.382M	$2.296M	$6.694M
YoY Change	-45.15%	6.96%	-22.61%
% of Gross Profit
Research & Development			$3.060M
YoY Change
% of Gross Profit
Depreciation & Amortization	$187.0K	$193.5K	$875.6K
YoY Change	-14.77%	-8.5%	16.51%
% of Gross Profit
Operating Expenses	$1.863M	$2.296M	$9.754M
YoY Change	-26.06%	6.96%	12.78%
Operating Profit	$30.80M		-$9.057M
YoY Change
Interest Expense	$5.450K	-$5.430K	-$3.410K
YoY Change	1996.15%	-2460.87%	-99.91%
% of Operating Profit	0.02%
Other Income/Expense, Net	$820.0K
YoY Change
Pretax Income	-$1.577M	-$2.143M	-$9.060M
YoY Change	-33.67%	13.43%	-21.8%
Income Tax
% Of Pretax Income
Net Earnings	-$1.577M	-$2.143M	-$9.060M
YoY Change	-33.67%	13.43%	-21.8%
Net Earnings / Revenue	-562.77%	-1359.87%	-1299.84%
Basic Earnings Per Share	-$0.06		-$0.39
Diluted Earnings Per Share	-$0.06	-$77.65K	-$0.39
COMMON SHARES
Basic Shares Outstanding	30.30M shares		23.27M shares
Diluted Shares Outstanding	27.42M shares		23.27M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.084M	$7.155M	$7.155M
YoY Change	-23.67%	-33.21%	-33.21%
Cash & Equivalents	$8.084M	$7.155M	$7.155M
Short-Term Investments
Other Short-Term Assets	$160.8K	$560.1K	$560.1K
YoY Change	-7.26%	87.07%	87.07%
Inventory
Prepaid Expenses
Receivables	$66.08K	$14.55K	$14.55K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.311M	$7.730M	$7.730M
YoY Change	-22.96%	-30.13%	-30.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$83.67K	$87.19K	$87.19K
YoY Change	-11.55%	-13.32%	-13.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.079M	$1.154M	$1.154M
YoY Change	-25.28%	-18.35%	-18.35%
TOTAL ASSETS
Total Short-Term Assets	$8.311M	$7.730M	$7.730M
Total Long-Term Assets	$1.079M	$1.154M	$1.154M
Total Assets	$9.390M	$8.884M	$8.884M
YoY Change	-23.23%	-28.8%	-28.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$33.90K	$122.3K	$122.3K
YoY Change	-83.85%	-12.5%	-12.49%
Accrued Expenses	$368.3K	$283.2K	$283.2K
YoY Change	-27.23%	5.34%	5.34%
Deferred Revenue	$341.7K	$342.7K
YoY Change	-16.53%	2.84%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$743.9K	$748.1K	$748.1K
YoY Change	-33.9%	0.86%	0.86%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$743.9K	$748.1K	$748.1K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$743.9K	$748.1K	$748.1K
YoY Change	-33.89%	0.86%	0.86%
SHAREHOLDERS EQUITY
Retained Earnings	-$30.85M	-$29.28M
YoY Change		44.81%
Common Stock	$2.990K	$2.559K
YoY Change		23.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.646M	$8.136M	$8.136M
YoY Change
Total Liabilities & Shareholders Equity	$9.390M	$8.884M	$8.884M
YoY Change	-23.23%	-28.8%	-28.8%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022
OPERATING ACTIVITIES
Net Income	-$1.577M	-$2.143M	-$9.060M
YoY Change	-33.67%	13.43%	-21.8%
Depreciation, Depletion And Amortization	$187.0K	$193.5K	$875.6K
YoY Change	-14.77%	-8.5%	16.51%
Cash From Operating Activities	-$809.8K	-$1.627M	-$6.716M
YoY Change	-33.04%	30.7%	25.89%
INVESTING ACTIVITIES
Capital Expenditures	$2.861K	-$123.2K	$16.58K
YoY Change	-101.05%	-28.49%	-101.97%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$112.4K	-$123.2K	-$711.6K
YoY Change	-58.85%	-28.49%	-15.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$3.870M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.851M	0.000	$3.870M
YoY Change	36.07%	-100.0%	-69.76%
NET CHANGE
Cash From Operating Activities	-$809.8K	-1.627M	-$6.716M
Cash From Investing Activities	-$112.4K	-123.2K	-$711.6K
Cash From Financing Activities	$1.851M	0.000	$3.870M
Net Change In Cash	$928.3K	-1.750M	-$3.558M
YoY Change	-857.7%	23.18%	-153.75%
FREE CASH FLOW
Cash From Operating Activities	-$809.8K	-$1.627M	-$6.716M
Capital Expenditures	$2.861K	-$123.2K	$16.58K
Free Cash Flow	-$812.6K	-$1.504M	-$6.732M
YoY Change	-13.2%	40.21%	49.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39553
CY2022	dei	Entity Registrant Name EntityRegistrantName	AMESITE INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-3431718
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	607 Shelby Street
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 700 PMB 214
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Detroit
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	48226
CY2022	dei	City Area Code CityAreaCode	(734)
CY2022	dei	Local Phone Number LocalPhoneNumber	876-8141
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001
CY2022	dei	Trading Symbol TradingSymbol	AMST
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q2	us-gaap	Assets Current AssetsCurrent	7729996	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5183863	usd
CY2021Q2	us-gaap	Assets Current AssetsCurrent	11063600	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4620431	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	87190	usd
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	100590	usd
CY2022Q2	amst	Capitalized Software Net CapitalizedSoftwareNet	1066674	usd
CY2022	amst	Technology And Content Development TechnologyAndContentDevelopment	3059962	usd
CY2021Q2	amst	Capitalized Software Net CapitalizedSoftwareNet	1312643	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1153864	usd
CY2021Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1413233	usd
CY2022Q2	us-gaap	Assets Assets	8883860	usd
CY2021Q2	us-gaap	Assets Assets	12476833	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	122285	usd
CY2022	amst	Acquisition Of Capitalized Software Included In Accounts Payable AcquisitionOfCapitalizedSoftwareIncludedInAccountsPayable		usd
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	139754	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	174056	usd
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	199908	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	342672	usd
CY2021Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	333200	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	109095	usd
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	68881	usd
CY2022	amst	Conversion Of Convertible Notes Payable Including Accrued Interest Of73315 Into113 Of Common Stock ConversionOfConvertibleNotesPayableIncludingAccruedInterestOf73315Into113OfCommonStock		usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	748108	usd
CY2021	amst	Technology And Content Development TechnologyAndContentDevelopment	2276555	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1509694	usd
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	741743	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Public Float EntityPublicFloat	22649369	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30300305	shares
CY2022	dei	Auditor Firm AuditorFirmId	34
CY2022	dei	Auditor Name AuditorName	Deloitte and Touche LLP
CY2022	dei	Auditor Location AuditorLocation	Detroit, MI
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	7155367	usd
CY2021Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	10713091	usd
CY2022Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	14545	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8883860	usd
CY2021Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	51120	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	560084	usd
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	299389	usd
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12476833	usd
CY2022	us-gaap	Revenues Revenues	697001	usd
CY2021	us-gaap	Revenues Revenues	674580	usd
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25993484	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25993484	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21063954	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21063954	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	2559	usd
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	2066	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	37410209	usd
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	31950117	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29277016	usd
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20217093	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8135752	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	11735090	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1751606	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	9753519	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	8648592	usd
CY2022	us-gaap	Other Noncash Income OtherNoncashIncome	9230	usd
CY2021	us-gaap	Other Noncash Income OtherNoncashIncome	1593	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	12635	usd
CY2021	us-gaap	Other Noncash Expense OtherNoncashExpense	3613873	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3405	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3612280	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-9059923	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-11586292	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23269590	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19500251	shares
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	2999896	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-11586292	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	13805830	usd
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	876295	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5639361	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	11735090	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9059923	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4018498	usd
CY2022	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	1442087	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8135752	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-9059923	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-11586292	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	875604	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	751498	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1442087	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	876295	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	182900	usd
CY2021	amst	Interest Expense On Notes Payable Converted To Common Stock InterestExpenseOnNotesPayableConvertedToCommonStock	3430858	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	148948	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1009601	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-36575	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	260695	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	72115	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	77918	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-46800	usd
CY2022	amst	Accrued Compensation AccruedCompensation	-25852	usd
CY2021	amst	Accrued Compensation AccruedCompensation	27701	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	9472	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	137423	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	40214	usd
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-55755	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6715652	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5334686	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16575	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	73427	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	695047	usd
CY2021	us-gaap	Payments For Software PaymentsForSoftware	768899	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-711622	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-842326	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3869550	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12796229	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3869550	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12796229	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3557724	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6619217	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10713091	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4093874	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7155367	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10713091	usd
CY2021	amst	Acquisition Of Capitalized Software Included In Accounts Payable AcquisitionOfCapitalizedSoftwareIncludedInAccountsPayable	95387	usd
CY2022	amst	Accrued Interest AccruedInterest	73315	usd
CY2021	amst	Accrued Interest AccruedInterest	73315	usd
CY2022	amst	Stock Issued During Period Shares Conversion Of Unit StockIssuedDuringPeriodSharesConversionOfUnit	1127872	shares
CY2021	amst	Stock Issued During Period Shares Conversion Of Unit StockIssuedDuringPeriodSharesConversionOfUnit	1127872	shares
CY2021	amst	Conversion Of Convertible Notes Payable Including Accrued Interest Of73315 Into113 Of Common Stock ConversionOfConvertibleNotesPayableIncludingAccruedInterestOf73315Into113OfCommonStock	2255745	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	148948	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	1009601	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1 - Nature of Business and Liquidity</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Amesite Inc. (the “Company”) was incorporated in November 2017. The Company is an artificial intelligence driven platform and course designer, that provides customized, high performance and scalable online products for schools and businesses. The Company uses machine learning to provide a novel, mass customized experience to learners. The Company’s Customers are businesses, universities and colleges, and a K-12 school. The Company’s activities are subject to significant risks and uncertainties. The Company’s operations are considered to be in one segment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On September 18, 2020, we consummated a reorganizational merger, pursuant to an Agreement and Plan of Merger (the “Merger Agreement”), dated July 14, 2020 (“Effective Date”), whereby we merged with and into Amesite Inc. (“Amesite Parent”) our former parent corporation, with our Company resulting as the surviving entity. In connection with the same, we filed a Certificate of Ownership and Merger with the Secretary of State of the State of Delaware, and changed our name from “Amesite Operating Company” to “Amesite Inc.” The stockholders of Amesite Parent approved the Merger Agreement on August 4, 2020. The directors and officers of Amesite Parent became our directors and officers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Pursuant to the Merger Agreement, on the Effective Date, each share of the Amesite parent’s common stock, $0.0001 par value per share, issued and outstanding immediately before the Effective Date, was converted, on a one-for-one basis, into shares of our common stock.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Additionally, each option or warrant to acquire shares of Amesite Parent outstanding immediately before the Effective Date was converted into and became an equivalent option to acquire shares of our common stock, upon the same terms and conditions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Going Concern</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The accompanying financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company is developing its customer base and has not completed its efforts to establish a stabilized source of revenue sufficient to cover its expenses. The Company has had a history of net losses and negative cash flows from operating activities since inception and expects to continue to incur net losses and use cash in its operations in the foreseeable future.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>In addition, the Company has received a notice from the Nasdaq related to their failure to maintain a minimum bid price of $1 per share. The Company is not currently in compliance with the Nasdaq listing rules and if the Company does not regain compliance, the common stock of the Company could be delisted from the Nasdaq exchange. If the Company’s common stock is delisted, it may affect the Company’s ability to obtain financing, trade or sell shares of their common stock, and/or forecasted operations could be negatively impacted in an amount that the Company cannot currently quantify.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The assessment of the Company’s ability to meet its future obligations is inherently judgmental, subjective and susceptible to change. <span>Based on their current forecast, management believes that it will have sufficient cash and cash equivalents to maintain the Company’s planned operations for the next twelve months following the issuance of these financial statements; however, there is uncertainty in the forecast and therefore the Company cannot assert that it is probable. The Company has considered both quantitative and qualitative factors that are known or reasonably knowable as of the date of these financial statements are issued and concluded that there are conditions present in the aggregate that raise substantial doubt about the Company’s ability to continue as a going concern. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>In response to the conditions, management plans include generating cash by completing financing transactions, which may include offerings of common stock. However, these plans are subject to market conditions, and are not within the Company’s control, and therefore, cannot be deemed probable. There is no assurance that the Company will be successful in implementing their plans. As a result, the Company has concluded that management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span>The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.</span></p>
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i> </i></b></p>
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	333200	usd
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	380000	usd
CY2022	amst	Contract With Customers Liability ContractWithCustomersLiability	706473	usd
CY2022Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022	amst	Scheduleof Straightlines Method Over The Estimated Useful Life Table Text Blick ScheduleofStraightlinesMethodOverTheEstimatedUsefulLifeTableTextBlick	<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Beginning balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2,650,422</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,881,523</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Additions</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">599,660</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">768,899</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 10pt; padding-left: 5.4pt">Total cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,250,082</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,650,422</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,183,408</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,337,779</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt; text-indent: 10pt; padding-left: 5.4pt">Closing balance</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,066,674</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,312,643</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p>
CY2022Q2	amst	Capitalized Computer Software Net Beginning Balance CapitalizedComputerSoftwareNetBeginningBalance	2650422	usd
CY2021Q2	amst	Capitalized Computer Software Net Beginning Balance CapitalizedComputerSoftwareNetBeginningBalance	1881523	usd
CY2022	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions	599660	usd
CY2022	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span><b><i>Property and Equipment</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Property and equipment are recorded at cost. The straight-line method is used for computing depreciation and amortization. Assets are depreciated over their estimated useful lives. The cost of leasehold improvements is depreciated (amortized) over the lesser of the length of the related leases or the estimated useful lives of the assets. Costs of maintenance and repairs are charged to expense when incurred.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p>
CY2021	amst	Contract With Customers Liability ContractWithCustomersLiability	627780	usd
CY2022	amst	Revenue Recognized From Continuing Operations RevenueRecognizedFromContinuingOperations	-697001	usd
CY2021	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions	768899	usd
CY2022Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	3250082	usd
CY2021Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	2650422	usd
CY2022Q2	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	2183408	usd
CY2021Q2	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	1337779	usd
CY2022Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1066674	usd
CY2021Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1312643	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	845629	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	733353	usd
CY2022Q2	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	697001	usd
CY2021Q2	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	674580	usd
CY2022	amst	Services Transferred ServicesTransferred	26900	usd
CY2021	amst	Services Transferred ServicesTransferred	163655	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	697001	usd
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	674580	usd
CY2021	amst	Revenue Recognized From Continuing Operations RevenueRecognizedFromContinuingOperations	-674580	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	342672	usd
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	333200	usd
CY2022	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	315590	usd
CY2021	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	220046	usd
CY2020Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	5
CY2020Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	12800000	usd
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.45
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3222125	shares
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P2Y
CY2022Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Risks and Uncertainties </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company operates in an industry subject to rapid change. The Company’s operations will be subject to significant risk and uncertainties including financial, operational, technological, and other risks associated with an early-stage company, including the potential risk of business failure.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On March 11, 2020, the World Health Organization declared the outbreak of a respiratory disease caused by a novel coronavirus as a “pandemic.” First identified in late 2019 and known now as COVID-19, the outbreak has impacted thousands of individuals worldwide. In response, many countries, including the United States, have implemented measures to combat the outbreak which have impacted global business operations. While management believes the Company’s operations have not been significantly impacted, the Company continues to monitor the situation. In addition, while the Company’s results of operations, cash flows and financial condition could be negatively impacted, the extent of the impact cannot be reasonably estimated at this time.</p>
CY2022	amst	Average Price Description AveragePriceDescription	If the average price is below $3.00 per share, the Company is limited to issuing 50,000 shares per request; if the share price is between $3.00 and $4.00 per share, the limit is 75,000 shares per request, if the share price is between $4.00 and $5.00, the limit is 100,000 shares per request, and if the share price is above $5.00, the limit is 150,000 shares per request. Requests for purchases are permitted daily as long as the Company’s stock price is above $0.50 per share.
CY2021Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	9901	shares
CY2021Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	9901	shares
CY2022Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	36960	usd
CY2021Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	36960	usd
CY2022Q2	amst	Computer Equipment ComputerEquipment	117094	usd
CY2021Q2	amst	Computer Equipment ComputerEquipment	100519	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	154054	usd
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	137479	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	66864	usd
CY2021Q2	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	36889	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	87190	usd
CY2021Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	100590	usd
CY2022	us-gaap	Depreciation Depreciation	29975	usd
CY2021	us-gaap	Depreciation Depreciation	18145	usd
CY2020Q3	amst	Private Placement Offering Description PrivatePlacementOfferingDescription	In connection with the Offering, the Company agreed to issue five (5) year warrants to the underwriter to purchase five percent (5%) of the number of common shares sold in the Offering for an exercise price equal to $6.00. Total warrants of 150,000 were issued to the underwriter on September 29, 2020.
CY2022	us-gaap	Description Of Fair Value Hedge Activity DescriptionOfFairValueHedgeActivity	The fair value of the warrants issued in connection with the Offering was approximately $249,000 based on the following inputs and assumptions using the BSM: (i) expected stock price volatility of 45.00%; (ii) risk free interest rate of .14%; and (iii) expected life of the warrants of 5 years. The warrants were fully vested on the date of grant and are included in offering costs in the Statement of Stockholders’ Equity.
CY2022	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1127872	shares
CY2022	amst	Warrants Issued WarrantsIssued	126532	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	6665	shares
CY2022	us-gaap	Product Warranty Expense ProductWarrantyExpense	15000	usd
CY2020Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	69709	shares
CY2020Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	69709	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	290000	usd
CY2020Q4	amst	Common Stock Total Approximate Value CommonStockTotalApproximateValue	106383	shares
CY2021Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	39437	shares
CY2022	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	759109	shares
CY2022	amst	Purchase Price PurchasePrice	1500000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1360000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	18218	usd
CY2021Q4	amst	Common Stock Total Approximate Value CommonStockTotalApproximateValue	4000	shares
CY2022Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	250000	shares
CY2022Q1	us-gaap	Shares Issued SharesIssued	3437500	shares
CY2022Q1	amst	Public Offering Price Per Share PublicOfferingPricePerShare	0.8
CY2022Q1	amst	Underwriting Agreement Shares UnderwritingAgreementShares	3750000	shares
CY2022Q1	amst	Shares Of Common Stock SharesOfCommonStock	3750000	shares
CY2022Q1	amst	Gross Proceed GrossProceed	3000000	usd
CY2022Q1	amst	Net Proceeds NetProceeds	2509550	usd
CY2022Q1	amst	Offering Warrant Issued OfferingWarrantIssued	P5Y
CY2022Q1	amst	Underwriter Of Purchase UnderwriterOFPurchase	187500	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1
CY2022Q2	amst	Warrants Issueds WarrantsIssueds	94165	usd
CY2022	us-gaap	Description Of Price Risk Exposure DescriptionOfPriceRiskExposure	(i) expected stock price volatility of 80.10%; (ii) risk free interest rate of 1.63%; and (iii) expected life of the warrants of 5 years.
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2962833	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1421739	shares
CY2021Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1234239	shares
CY2022	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	1
CY2021	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	6
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	94165	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	249000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.801	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0163	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.001	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4600000	shares
CY2022	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1 ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1	P7Y
CY2021	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1 ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1	P5Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0012	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.82
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	566000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.97
CY2021	amst	Share Based Compensation Arrangement By Shares Based Payment Award Weighted Average Remaining Contractual Termin Years Granted ShareBasedCompensationArrangementBySharesBasedPaymentAwardWeightedAverageRemainingContractualTerminYearsGranted	P9Y7M24D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	306708	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.96
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P8Y4M2D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	129024	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.76
CY2022	amst	Share Based Compensation Arrangement By Shares Based Payment Award Weighted Average Remaining Contractual Termin Years Granted ShareBasedCompensationArrangementBySharesBasedPaymentAwardWeightedAverageRemainingContractualTerminYearsGranted	P9Y3M3D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	187959	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.01
CY2022	amst	Shares Based Compensation Arrangement By Share Based Payment Award Weighted Average Remaining Contractual Termin Years Terminated SharesBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageRemainingContractualTerminYearsTerminated	P8Y8M8D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3163190	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.89
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P7Y4M2D
CY2022	amst	Weightedaverage Grantdate Fair Value Of Options Granted WeightedaverageGrantdateFairValueOfOptionsGranted	1.76
CY2021	amst	Weightedaverage Grantdate Fair Value Of Options Granted WeightedaverageGrantdateFairValueOfOptionsGranted	1.29
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	129024	shares
CY2021	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	566000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	187959	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	306708	shares
CY2021Q3	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	172702	usd
CY2021Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	600000	usd
CY2021Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	337078	shares
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	130486	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	600000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	1442087	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	876295	usd
CY2022	amst	Unrecognized Compensation Expense UnrecognizedCompensationExpense	280801	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1894858	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2433121	usd
CY2022	amst	State Income Tax StateIncomeTax	-451344	usd
CY2021	amst	State Income Tax StateIncomeTax	-374728	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2440991	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2070288	usd
CY2022	amst	Permanent Differences PermanentDifferences	125216	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	710560	usd
CY2022	amst	Prior Period Adjustment PriorPeriodAdjustment	-220005	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	27001	usd
CY2020Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2182500	usd
CY2020Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2182500	usd
CY2022	amst	Unsecured Bear Interest UnsecuredBearInterest	0.08	pure
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6000166	usd
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3863935	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	771816	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	522836	usd
CY2022Q2	amst	Capitalization Of Startup Costs For Tax Purposes CapitalizationOfStartupCostsForTaxPurposes	114800	usd
CY2021Q2	amst	Capitalization Of Startup Costs For Tax Purposes CapitalizationOfStartupCostsForTaxPurposes	125004	usd
CY2022Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3560	usd
CY2021Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	5148	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	35559	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	42214	usd
CY2022Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	17255	usd
CY2021Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	149	usd
CY2022Q2	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	3913	usd
CY2021Q2	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	3777	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6947069	usd
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4563063	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6666179	usd
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4225188	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	280890	usd
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	337875	usd
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	280890	usd
CY2021Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	337875	usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	280890	usd
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	337875	usd
CY2022Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	23300000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	23.3	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	23300000	usd
CY2022	amst	Expired Amount ExpiredAmount	17000	usd
CY2022	amst	Utilization Utilization	0.80	pure
CY2022	amst	Dates Of Issuance DatesOfIssuance	P1Y
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	2
CY2022	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.75	pure
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	261900	usd
CY2022Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	2255815	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1127872	shares
CY2022Q2	us-gaap	Share Price SharePrice	2
CY2022	amst	Offering Price Per Share OfferingPricePerShare	5
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3383546	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	182900	usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19500251	shares
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2022	amst	Interest Expense On Notes Payable Converted To Common Stock InterestExpenseOnNotesPayableConvertedToCommonStock		usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P906Y
CY2021	amst	Shares Based Compensation Arrangement By Share Based Payment Award Weighted Average Remaining Contractual Termin Years Terminated SharesBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageRemainingContractualTerminYearsTerminated
CY2021	amst	Permanent Differences PermanentDifferences		usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense		usd
CY2021	amst	Prior Period Adjustment PriorPeriodAdjustment		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2021Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001807166

Files In Submission

Name	View Source	Status
0001213900-22-059740-index-headers.html	Edgar Link	pending
0001213900-22-059740-index.html	Edgar Link	pending
0001213900-22-059740.txt	Edgar Link	pending
0001213900-22-059740-xbrl.zip	Edgar Link	pending
amst-20220630.xsd	Edgar Link	pending
f10k2022ex23-1_amesiteinc.htm	Edgar Link	pending
f10k2022ex31-1_amesiteinc.htm	Edgar Link	pending
f10k2022ex31-2_amesiteinc.htm	Edgar Link	pending
f10k2022ex32-1_amesiteinc.htm	Edgar Link	pending
f10k2022ex32-2_amesiteinc.htm	Edgar Link	pending
f10k2022_amesiteinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
amst-20220630_pre.xml	Edgar Link	unprocessable
amst-20220630_cal.xml	Edgar Link	unprocessable
amst-20220630_def.xml	Edgar Link	unprocessable
amst-20220630_lab.xml	Edgar Link	unprocessable
f10k2022_amesiteinc_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMST
Amesite Inc. Stock $amst

2022 Q3 Form 10-K Financial Statement

#000121390022059740 Filed on September 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMST Amesite Inc. Stock $amst

2022 Q3 Form 10-K Financial Statement

#000121390022059740 Filed on September 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMST
Amesite Inc. Stock $amst